Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Ligand Pharmaceuticals Set to Join the S&P SmallCap 600 PR Newswire NEW YORK, Nov. 25, 2013 NEW YORK, Nov. 25, 2013 /PRNewswire/ -- Ligand Pharmaceuticals Inc. (NASD: LGND) will replace SHFL...
Combination creates a world-class, end-to-end gaming technology innovator with the industry’s most diversified product suite and several successful brands Bally Technologies, Inc...
SHFL Shareholders Approve Merger Agreement With Bally Technologies PR Newswire LAS VEGAS, Nov. 19, 2013 LAS VEGAS, Nov. 19, 2013 /PRNewswire/ -- SHFL entertainment, Inc. (NASDAQ Global Select...
SHFL Schedules Special Shareholder Meeting for November 19, 2013 to Vote on Approval and Adoption of the Merger Agreement with Bally PR Newswire LAS VEGAS, Oct. 10, 2013 LAS VEGAS, Oct. 10, 2013...
SHFL entertainment Installs its SHFL Fusion Hybrid e-Tables at Resorts World Manila PR Newswire LAS VEGAS, Sept. 25, 2013 LAS VEGAS, Sept. 25, 2013 /PRNewswire/ -- SHFL entertainment, Inc...
Experience "The Only Way to Play" with SHFL entertainment's Intriguing Lineup of New Innovations at the 2013 Global Gaming Expo PR Newswire LAS VEGAS, Sept. 20, 2013 LAS VEGAS, Sept...
SHFL entertainment, Inc. Reports Revenue Of $73.5 Million In Third Quarter, Up 16% Year-Over-Year PR Newswire LAS VEGAS, Sept. 6, 2013 LAS VEGAS, Sept. 6, 2013 /PRNewswire/ -- SHFL entertainment...
Hart-Scott-Rodino Waiting Period Expires For Bally Technologies' Acquisition Of SHFL entertainment PR Newswire LAS VEGAS, Aug. 27, 2013 LAS VEGAS, Aug. 27, 2013 /PRNewswire/ -- Bally...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
